Your browser doesn't support javascript.
loading
Impact of residual risk messaging to reduce false reassurance following test-negative results from asymptomatic coronavirus (SARS-CoV-2) testing: an online experimental study of a hypothetical test.
Batteux, Eleonore; Bonfield, Stefanie; Jones, Leah Ffion; Carter, Holly; Gold, Natalie; Amlot, Richard; Marteau, Theresa; Weston, Dale.
Afiliação
  • Batteux E; Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK e.batteux@ucl.ac.uk.
  • Bonfield S; Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.
  • Jones LF; Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.
  • Carter H; Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.
  • Gold N; Department of Behavioural Insights, Public Health England, London, UK.
  • Amlot R; Centre for the Philosophy of Natural and Social Science, The London School of Economics and Political Science, London, UK.
  • Marteau T; Behavioural Science and Insights Unit, UK Health Security Agency, Salisbury, UK.
  • Weston D; Department of Psychological Medicine, King's College London, London, UK.
BMJ Open ; 12(3): e056533, 2022 03 16.
Article em En | MEDLINE | ID: mdl-35296483
OBJECTIVES: Individuals who receive a negative lateral flow coronavirus test result may misunderstand it as meaning 'no risk of infectiousness', giving false reassurance. This experiment tested the impact of adding information to negative test result messages about residual risk and the need to continue protective behaviours. DESIGN: 4 (residual risk) × 2 (post-test result behaviours) between-subjects design. SETTING: Online. PARTICIPANTS: 1200 adults from a representative UK sample recruited via Prolific (12-15 March 2021). INTERVENTIONS: Participants were randomly allocated to one of eight messages. Residual risk messages were: (1) 'Your coronavirus test result is negative' (control); (2) message 1 plus 'It's likely you were not infectious when the test was done' (current NHS Test & Trace (T&T); (3) message 2 plus 'But there is still a chance you may be infectious' (elaborated NHS T&T); and (4) message 3 plus infographic depicting residual risk (elaborated NHS T&T+infographic). Each message contained either no additional information or information about the need to continue following guidelines and protective behaviours. OUTCOME MEASURES: (1) Proportion understanding residual risk of infectiousness and (2) likelihood of engaging in protective behaviours (scales 1-7). RESULTS: The control message decreased understanding relative to the current NHS T&T message: 54% versus 71% (Adjusted Odds Ratio (AOR)=0.56 95% CI 0.34 to 0.95, p=0.030). Understanding increased with the elaborated NHS T&T (89%; AOR=3.25 95% CI 1.64 to 6.42, p=0.001) and elaborated NHS T&T+infographic (91%; AOR=5.16 95% CI 2.47 to 10.82, p<0.001) compared with current NHS T&T message. Likelihood of engaging in protective behaviours was unaffected by information (AOR=1.11 95% CI 0.69 to 1.80, χ2(1)=0.18, p=0.669), being high (M=6.4, SD=0.9) across the sample. CONCLUSIONS: A considerable proportion of participants misunderstood the residual risk following a negative test result. The addition of a single sentence ('But there is still a chance you may be infectious') to current NHS T&T wording increased understanding of residual risk. TRIAL REGISTRATION NUMBER: OSF: https://osf.io/byfz3/.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: BMJ Open Ano de publicação: 2022 Tipo de documento: Article